semaglutide wellington man Finlay Thompson on weight loss drug Wegovy after Medsafe approval Semaglutide Wegovy® - Prefilled Pen

The recommended starting doses are as follows: For patients nave to basal insulin or to a GLP-1 RA, currently on less than 30 units of basal insulin, or on a GLP-1 RA: Start at 15 units subcutaneously once daily within 60 minutes of the first meal of the day

The same approach applies to 25 mg and 100 mg tablets

doi: 10.1016/j.redox.2019.101255 379 WeinbergSESenaLAChandelNS

That alone would make tirzepatide an interesting story

Head-to-head post-registration trial or a real-world data study would be helpful

These symptoms seem to be related more to weight loss itself or other personal health factors than to the medication directly